추출조건을 달리한 마늘 추출물이 Triton WR-1339 유발 고지혈증 흰쥐의 체내 지질대사에 미치는 영향

키워드

참고문헌 (45)

1. Annual report of mortality statistics, "Korea National Statistical Office", ~ (2005)
2. Report on 2005 National Health and Nutrition Survey, "Ministry of Health and Welfare", ~ (2006)
3. Culter RG, "antioxidants aging and longevity. In Free Radicals in Biology", pp.371~423 (1984), Academic Press
4. 권순경, "마늘의 유기유황성분과 생리활성", 응용약물학회지, 11(1), pp.8~32 (2003), 한국응용약물학회
5. Huh J, "Jeuungbo Dogneubogam", pp.1172~ (1981), Namsandang
6. Kim CM, "The encyclopedia of oriental herbal medicine" (2003), Jeung Dam Pub
7. Choi HK, "study on the antibacterial activity of garlic against Escherichia coli 0157", J Korean Practical Arts Edu, 14, pp.159~167 (2001)
8. Lemar KM, "Garlic(Allium sativum) as an anti-candida agent : a comparison of the efficacy of fresh garlic and freeze-dried extracts", J Appl Microbiol., 93, pp.398~405 (2002)
9. Yin MC, "Inhibitory effect of seven Allium plants upon three Aspergillus species", Int. J Food Microbiol, 49, pp.49~56 (1999)
10. Ruffin J, "An evaluation of the effect of garlic as an antihypertensive agent", Ctyobios, 37, pp.85~89 (1983)
11. Ackermann RT, "Garlic shows promise for improving some cardiovascular risk factors", Arch Intern Med., 161, pp.813~824 (2001)
12. Banerjee S, "Effect of garlic on cardiovascular disorder. review", Nutr J., 1, pp.4~ (2002)
13. Kim ES, "The anticarcinogenic effect of garlic juice against DMBA induced carcinoma on the hamster buccal pouch (in korean)", J Korean Soc Food Nutr., 22, pp.398~404 (1993)
14. Takezaki T, "Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province, China : Comparison with those in a high-epidemic area", Jpn J Cancer Res., 92, pp.1157~1165 (2001)
15. Takezaki T, "Comparative study of ligestyles of residents in high and low risk areas for gastric cancer in Jiangsu province, China : with special reference to Allium vegetables", J Epidemiol, 9, pp.297~305 (1999)
16. Iciek MB, "Effects of diallyl disulfide and other donors if sulfane sulfur on the proliferation of human hepatoma cell line(Hep G2)", Neoplasma, 48, pp.307~312 (2001)
17. Lea MA, "Induction of histone acetylation in rat liver and hepatoma by organosulfur compounds including diallyl disulfide", Anticancer Res., 21, pp.2841~2845 (2001)
18. Yamasaki T, "Garlic compounds protect vascular endothelial cells from oxidant injury", Nippon Yakurigaku Zasshi, 110(1), pp.138~141 (1997)
19. Kusama H, "Pharmacological investigation of bezafibrate, a hypolipidemic agent(Ⅰ). Effect of bezafibrate on mormal experimental hyperlipidemia in rats", Folia Pharmacol Japon., 92, pp.175~180 (1988)
20. Jung HJ, "The MeOH extract of Pleurospermum kamtschaticum and its active component buddlejasaponin (IV) inhibits intrinsic and extrinsic hyperlipidemia and hypercholesterolemia in the rat", J Ethnopharmacol, 112(2), pp.255~261 (2007)
21. Oh PS, "Hypolipidemic and antioxidative effects of the plant glycoprotein( 36kDa) from Rhus verniciflua stokes fruit in Triton WR-1339-induced hyperlipidemic mice", Biosci Biotechnol Biochem., 70(2), pp.447~456 (2006)
22. Lee IA, "Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin", Biol Pharm Bull, 28(11), pp.2106~2110 (2005)
23. 최호영, "국산과 중국산 枳實의 Triton WR-1339 유발 高脂血症 흰쥐에 대한 효능 연구", 대한본초학회지, 22(3), pp.109~116 (2007), 대한본초학회
24. Folch J, "A simple method for the isolation and purification of total lipid from animal tissues", J Bio Chem., 226, pp.497~509 (1957)
25. Fauci AS, "Harrison's principles of intermal medicine 14th ed", pp.2139~ (1994), McGraw-Hill Hesgpth Professions Division
26. Catlos T, "Sandritter's color atlas & textbook of Histopathology, 7th ed", pp.153~155 (1984), Year Book Med. Co.
27. Hayashi H, "The origin of lipid accumulated in the liver lysosomes after administration of triton WR-1339", J Biochem., 92(5), pp.1585~1590 (1982)
28. Venkatesan S, "Effect of chronic ethanol feeding on the hepatic secretion of VLDL", Biochim Biophys Acta., 960(1), pp.61~66 (1988)
29. Robbins SL, "Robbins pathologic basis of disease. 4th edition", pp.556~561 (1989), W.B. Saunders
30. Dalin R, "Study on Antihypertensive and Antihyperlipidemic effects of marine algae", Fisheries Science, 60(1), pp.83~88 (1994)
31. Hermier D, "Effect of lipase inhibitor, Triton WR-1339 and tetrahydrolipstatin, on the synthesis and secretion of lipids by rat hepatocytes", FEBS Lett., 285(1), pp.186~188 (1991)
32. Gerber LE, "Hyperlipidemia in rat fed retinoic acid", Lipids, 16(7), pp.496~501 (1981)
33. Kozarsky KF, "In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses", J Bio Chem., 269(18), pp.695~702 (1994)
34. Noriaki K, "Induction of mRNA for LDL receptors in heterozygous Watanabe Heritable Hyperlipidemic Rabbit treated with CS-514(Pravastatin) and Cholestyramine", Circulation, 79(5), pp.1084~1090 (1989)
35. Vushkin ML, "Activity of cholesterol metabolism enzymes and lipid levels in the rat liver, aorta, adrenals and serum after exposure to Triton WR-1339", Vopr Med Khim, 32(3), pp.98~101 (1986)
36. 방혜정, "고지혈증의 처방에 관한 문 헌적 고찰", 동서의학, 21(2), pp.70~81 (1996)
37. Hirsch RL, "The pathogensis of hyperlipidemia induced by means of surface-active agents. I. Increased total body cholesterol in mice given Triton WR- 1339 parenterally", J Exp. Med., 104, pp.1~13 (1956)
38. Goldfarb S, "Rapid increase in hepatic HMG-CoA reductase activity and in vivo cholesterol synthesis after Triton WR- 1339 injection", J Lipid Res., 19, pp.489~494 (1978)
39. Kui NY, "Clinical pathology file, 3th ed", pp.95~98 (2000), EuiHak Publishing & Printing Company
40. Hue FS, "Interactions of dietary calcium with toxic levels of lead and zinc in pigs", J Nutr., 105, pp.112~ (1975)
41. Lim YK, "Clinical application of biochemical test" (1980), Komoonsa
42. Anber V, "Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycan", Atherosclerosis, 124, pp.261~271 (1996)
43. Austin MA, "Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors of coronary heart disease in older Japanese-American men", Am J Cardiol., 86, pp.412~416 (2000)
44. Guerin M, "Feno-fibrate reduces plasma cholesterol ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia", Arterioscler Thromb Vasc Biol, 16, pp.763~772 (1996)
45. 박정의, "관상동맥경화증 위험 인자의 역학 연구", 한국지질학회지 제14차 추계학술대회, 통권 : 7, pp.101~108 (1997)

관련 논문AI추천